Supplement for Guselkumab induction therapy demonstrates long-lasting efficacy in patients with mild psoriasis, results from a randomized, placebo-controlled exploratory clinical trial
Published: 3 October 2023| Version 1 | DOI: 10.17632/nf2f873kvt.1
Contributor:
Jannik RDescription
Supplementary data pertaining to “Guselkumab induction therapy demonstrates long-lasting efficacy in patients with mild psoriasis, results from a randomized, placebo-controlled exploratory clinical trial” by J. Rousel, et al. (2023), published in the Journal of the American Academy of Dermatology.
Files
Categories
Dermatology, Psoriasis